Stonebridge Capital Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29	Closed	-$41	–	974
2023 Q2	$41	Hold	29	–	–	﹤0.01%	919
2023 Q1	$44	Buy	+29	New	+$44	﹤0.01%	931